Search research articles
Contact Us
Filters
Showing results (71-80 of 92) with videos related to
Page
of 10
Sort By:
Blood
|
June 8, 2017
Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response
Michael D Amatangelo, Lynn Quek, Alan Shih, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo
Janeta Popovici-Muller, Jeffrey O Saunders, Francesco G Salituro, et al.
Genes & Development
|
August 29, 2012
D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function
Masato Sasaki, Christiane B Knobbe, Momoe Itsumi, et al.
Alimentary Pharmacology & Therapeutics
|
May 25, 2016
Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis
W J Sandborn, B R Bhandari, R Fogel, et al.
Journal of Medicinal Chemistry
|
February 9, 2026
Discovery and Optimization of Orally Bioavailable Heterobifunctional Degraders of KAT2A/B for the Treatment of Cancer
James Neef, Kimberly S Straley, Chinmoy Mukherjee, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
September 27, 2023
Altered hepatic and intestinal homeostasis in a neonatal murine model of short-term total parenteral nutrition and antibiotics
Tahliyah S Mims, Roshan Kumari, Cameron Leathem, et al.
Journal of Neuro-Oncology
|
October 22, 2011
Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy
Whitney B Pope, Robert M Prins, M Albert Thomas, et al.
Blood
|
October 18, 2012
Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response
Amir T Fathi, Hossein Sadrzadeh, Darrell R Borger, et al.
Nature
|
June 19, 2010
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang, David W White, Stefan Gross, et al.
Nature
|
November 26, 2009
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang, David W White, Stefan Gross, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 92) with videos related to
Sort By:
Page
of 10
Blood
|
June 8, 2017
Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response
Michael D Amatangelo, Lynn Quek, Alan Shih, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo
Janeta Popovici-Muller, Jeffrey O Saunders, Francesco G Salituro, et al.
Genes & Development
|
August 29, 2012
D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function
Masato Sasaki, Christiane B Knobbe, Momoe Itsumi, et al.
Alimentary Pharmacology & Therapeutics
|
May 25, 2016
Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis
W J Sandborn, B R Bhandari, R Fogel, et al.
Journal of Medicinal Chemistry
|
February 9, 2026
Discovery and Optimization of Orally Bioavailable Heterobifunctional Degraders of KAT2A/B for the Treatment of Cancer
James Neef, Kimberly S Straley, Chinmoy Mukherjee, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
September 27, 2023
Altered hepatic and intestinal homeostasis in a neonatal murine model of short-term total parenteral nutrition and antibiotics
Tahliyah S Mims, Roshan Kumari, Cameron Leathem, et al.
Journal of Neuro-Oncology
|
October 22, 2011
Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy
Whitney B Pope, Robert M Prins, M Albert Thomas, et al.
Blood
|
October 18, 2012
Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response
Amir T Fathi, Hossein Sadrzadeh, Darrell R Borger, et al.
Nature
|
June 19, 2010
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang, David W White, Stefan Gross, et al.
Nature
|
November 26, 2009
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang, David W White, Stefan Gross, et al.
Page
of 10